BC Platforms launches BC Catalyst, first-to-market, AI-native analytics product that accelerates precision medicine
BC Catalyst transforms genomic and real-world data into fast, actionable insights to advance precision medicine at scale.
BC Catalyst transforms genomic and real-world data into fast, actionable insights to advance precision medicine at scale.
BC Platforms launches its EHDS-Ready Trusted Research Environment, enabling EU healthcare institutions to meet upcoming EHDS regulations with secure, automated and AI-driven tools.
BC Platforms, Modirum, VEIL.AI and Productivity Leap introduce an AI-enabled reference architecture that automates EHDS2 data discovery, access and secure analysis.
BC Platforms and NTT Life Science Corporation form an exclusive collaboration to drive data-driven medicine and strengthen Real-World Data capabilities worldwide.
BC Platforms acquires Medexprim, expanding our ability to deliver secure access to Real-World clinical and imaging Data for global biopharma across Europe.
BC Platforms and NTT join forces to integrate and harmonize Japanese healthcare data, supporting data-driven medicine and nationwide personalized care.